Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
This examination of a large international sample of adults highlights the prominence of therapeutic and wellness motivations for microdosing psychedelic drugs and identified lower levels of anxiety and depression among microdosers relative to controls.
Comparisons of psilocybin to LSD microdosers indicated no differences on measures of Depression, Anxiety and Stress from the DASS-21 (all values for F (1, 827) < 1.0, p > 0.50). The inclusion of a non-microdose comparison group that was similar with regard to important demographics, substance use, and mental health factors constitutes a distinct contribution of our findings to understanding mental health and microdosing… In order to have physical dependence your body needs to start relying on a substance to function properly. …there does not appear to be any sort of physiological mechanism that would make your body “dependent” on psilocin in such a way that you’d experience physical effects from stopping a regimen. In other words, no, you’re not going to have classically-defined physical “withdrawals” from microdosing.
Original Article (Nature & Lucid News):
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers & Can you experience psilocybin withdrawal if you stop microdosing?
Artwork Fair Use: James St. John
